NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Datavault AI's Smart Contracts IP Licensing to Wellgistics Health
TL;DR
Datavault AI's smart contract licensing gives Wellgistics Health a competitive edge by reducing PBM costs and enhancing transparency across 6,500+ pharmacies.
Datavault AI's smart contracts integrate with PharmacyChain and EinsteinRx platforms using Web 3.0 technology to automate prescription tracking and pharmaceutical distribution.
This partnership modernizes pharmaceutical distribution by improving prescription transparency and reducing healthcare costs, creating a more efficient system for patients and providers.
Datavault AI's Web 3.0 smart contracts now power prescription tracking across 6,500+ pharmacies through Wellgistics' PharmacyChain and EinsteinRx platforms.
Found this article helpful?
Share it with your network and spread the knowledge!
Datavault AI has exclusively licensed its proprietary smart contracts intellectual property to Wellgistics Health for integration into PharmacyChain™ and EinsteinRx™ platforms.
It enables Web 3.0 smart contract functions across a network of more than 6,500 pharmacies and supports Wellgistics' plan to streamline prescription tracking, reduce PBM-driven costs, enhance transparency for payers, and modernize U.S. pharmaceutical distribution.
The smart contracts will be integrated into Wellgistics Health's PharmacyChain™ and EinsteinRx™ platforms.
The network includes more than 6,500 pharmacies that will have access to these Web 3.0 smart contract functions.
The partnership aims to streamline prescription tracking, reduce PBM-driven costs, enhance transparency for payers, and modernize U.S. pharmaceutical distribution through data automation and AI integration.
Datavault AI leads in AI experience, valuation, and monetization of assets in the Web 3.0 environment, with cloud-based platform solutions serving multiple industries including healthcare, fintech, real estate, and more.
The company operates Acoustic Science and Data Science Divisions, featuring patented technologies like WiSA®, ADIO®, Sumerian®, and the Information Data Exchange® (IDE) for Digital Twins and NIL licensing.
The company is headquartered in Philadelphia, PA.
The latest news and updates relating to DVLT are available in the company's newsroom at https://www.investorbrandnetwork.com/clients/datavault-ai-inc/
The IDE enables Digital Twins and licensing of name, image, and likeness (NIL) by securely attaching physical real-world objects to immutable metadata objects, fostering responsible AI with integrity.
Curated from InvestorBrandNetwork (IBN)
